Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma

Human Pathology

Volumn 30, Issue 6, 1999, Pages 695-700

  Khoor, Andras ^a   Whitsett, Jeffrey A ^b   Stahlman, Mildred T ^b   Olson, Sandra J ^b   Cagle, Philip T ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

Adenocarcinoma; Lung; Malignant mesothelioma; proSP B; TTF 1

Indexed keywords

BIOTIN; HOMEODOMAIN PROTEIN; STREPTAVIDIN; SURFACTANT PROTEIN B; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CLARA CELL; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; MALIGNANT MESOTHELIOMA; MALIGNANT TRANSFORMATION; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; TISSUE SPECIFICITY;

EID: 0032997034     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90096-5     Document Type: Article

References (37)

1. Landis SH, Murray T, Bolden S, et al: Cancer statistics, 1998. CA Cancer J Clin 48:6-29, 1998
2. Travis WD, Travis LB, Devesa SS: Lung cancer. Cancer 75:191-202, 1995
3. Koss M, Travis W, Moran C, et al: Pseudomesotheliomatous adenocarcinoma: A reappraisal. Semin Diagn Pathol 9:117-123, 1992
4. Cagle PT, Wessels R, Greenberg SD: Concurrent mesothelioma and adenocarcinoma of the lung in a patient with asbestosis. Mod Pathol 6:438-441, 1993
5. McCaughey WT, Colby TV, Battifora H, et al: Diagnosis of diffuse malignant mesothelioma: Experience of a US/Canadian Mesothelioma Panel. Mod Pathol 4:342-353, 1991
6. Andrion A, Magnani C, Betta PG, et al: Malignant mesothelioma of the pleura: Interobserver variability. J Clin Pathol 48:856-860, 1995
7. Wick MR: Immunophenotyping of malignant mesothelioma. Am J Surg Pathol 21:1395-1398, 1997
8. Weaver TE, Whitsett JA: Function and regulation of expression of pulmonary surfactant-associated proteins. Biochem J 273:249-264, 1991
9. Khoor A, Gray ME, Hull WM, et al: Developmental expression of SP-A and SP-A mRNA in the proximal and distal respiratory epithelium in the human fetus and newborn. J Histochem Cytochem 41:1311-1319, 1993
10. Khoor A, Stahlman MT, Gray ME, et al: Temporal-spatial distribution of SP-B and SP-C proteins and mRNAs in developing respiratory epithelium of human lung. J Histochem Cytochem 42:1187-1199, 1994
11. Singh G, Singh J, Katyal SL, et al: Identification, cellular localization, isolation, and characterization of human Clara cell-specific 10 KD protein. J Histochem Cytochem 36:73-80, 1988
12. Khoor A, Gray ME, Singh G, et al: Ontogeny of Clara cell-specific protein and its mRNA: Their association with neuroepithelial bodies in human fetal lung and in bronchopulmonary dysplasia. J Histochem Cytochem 44:1429-1438, 1996
13. Lazzaro D, Price M, de Felice M, et al: The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 113:1093-1104, 1991
14. Stahlman MT, Gray ME, Whitsett JA: Expression of thyroid transcription factor-1 (TTF-1) in fetal and neonatal human lung. J Histochem Cytochem 44:673-678, 1996
15. Korfhagen TR, Whitsett JA: Transcriptional control in the developing lung: The Parker B. Francis lectureship. Chest 111:83S-88S, 1997
16. Zhang L, Whitsett JA, Stripp BR: Regulation of Clara cell secretory protein gene transcription by thyroid transcription factor-1. Biochim Biophys Acta 1350:359-367, 1997
17. Gazdar AF, Linnoila RI, Kurita Y, et al: Peripheral airway cell differentiation in human lung cancer cell lines. Cancer Res 50:5481-5487, 1990
18. Singh G, Scheithauer BW, Katyal SL: The pathobiologic features of carcinomas of type II pneumocytes: An immunocytologic study. Cancer 57:994-999, 1986
19. Mizutani Y, Nakajima T, Morinaga S, et al: Immunohistochemical localization of pulmonary surfactant apoproteins in various lung tumors: Special reference to nonmucus producing lung adenocarcinomas. Cancer 61:532-537, 1988
20. Noguchi M, Nakajima T, Hirohashi S, et al: Immunohistochemical distinction of malignant mesothelioma from pulmonary adenocarcinoma with anti-surfactant apoprotein, anti-Lewisa, and anti-Tn antibodies. HUM PATHOL 20:53-57, 1989
21. Linnoila RI, Jensen SM, Steinberg SM, et al: Peripheral airway cell marker expression in non-small cell lung carcinoma: Association with distinct clinicopathologic features. Am J Clin Pathol 97:233-243, 1992
22. Khoor A, Whitsett JA, Stahlman MT, et al: Expression of surfactant protein B precursor and surfactant protein B mRNA in adenocarcinoma of the lung. Mod Pathol 10:62-67, 1997
23. Bejarano PA, Baughman RP, Biddinger PW, et al: Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. Mod Pathol 9:445-452, 1996
24. Broers JL, Jensen SM, Travis WD, et al: Expression of surfactant associated protein-A and Clara cell 10 kilodalton mRNA in neoplastic and non-neoplastic human lung tissue as detected by in situ hybridization. Lab Invest 66:337-346, 1992
25. The World Health Organization histological typing of lung tumours. Second edition. Am J Clin Pathol 77:123-136, 1982
26. O'Reilly MA, Gazdar AF, Clark JC, et al: Glucocorticoids regulate surfactant protein synthesis in a pulmonary adenocarcinoma cell line. Am J Physiol 257:L385-L392, 1989
27. Holzinger A, Dingle S, Bejarano PA, et al: Monoclonal antibody to thyroid transcription factor-1: Production, characterization, and usefulness in tumor diagnosis. Hybridoma 15:49-53, 1996
28. Voorhout WF, Veenendaal T, Haagsman HP, et al: Intracellular processing of pulmonary surfactant protein B in an endosomal/ lysosomal compartment. Am J Physiol 263:L479-L486, 1992
29. Elston RC, Johnson WD: Essentials of Biostatistics. Philadelphia, PA, FA Davis, 1987
30. Shimosato Y: Pulmonary neoplasms, in Sternberg SS (ed): Diagnostic Surgical Pathology, vol 1 (ed 2). New York, NY, Raven Press, 1994, pp 1045-1093
31. Wick MR, Loy T, Mills SE, et al: Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: A histochemical, ultrastructural, and immunohistologic study of 103 cases. HUM PATHOL 21:759-766, 1990
32. Ordonez NG: The value of antibodies 44-3A6, SM3, HBME-1, and thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma: A comparative study with other commonly used antibodies. Am J Surg Pathol 21:1399-1408, 1997
33. Riera JR, Astengo-Osuna C, Longmate JA, et al: The immunohistochemical diagnostic panel for epithelial mesothelioma: A reevaluation after heat-induced epitope retrieval. Am J Surg Pathol 21:1409-1419, 1997
34. Di Loreto C, Puglisi F, Di Lauro V, et al: TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung. Cancer Lett 124:73-78, 1998
35. Bohinski RJ, Di Lauro R, Whitsett JA: The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis. Mol Cell Biol 14:5671-5681, 1994
36. Bruno MD, Bohinski RJ, Huelsman KM, et al: Lung cell-specific expression of the murine surfactant protein A (SP-A) gene is mediated by interactions between the SP-A promoter and thyroid transcription factor-1. J Biol Chem 270:6531-6536, 1995
37. Kimura S, Hara Y, Pineau T, et al: The T/ebp null mouse: Thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 10:60-69, 1996